Wednesday, April 20
WAYH - Safeguarding The Safeguards Of Medicine
Ominous. That was the tone of conversation at a local biotech conference. With the purchase this month of Cambridge-based Genzyme by the French pharmaceutical giant Sanofi, local biotech executives are concerned that our smaller homegrown biotechs are increasing takeover targets by large multinational firms. While corporate ownership can bring funding and resources, scientist worry about losing the creative, entrepreneurial spirit that put Kendall Square on the biotech map. Christoph Westphal, chair of the venture capital firm, Longwood Founders Fund, joins us.